ADENOMYOSIS. ETIOPHATOGENICAL, DIAGNOSTIC AND THERAPEUTICAL CONSIDERATIONS

Similar documents
What is endometrial cancer?

Endometrial Stromal Sarcoma

Ph.D. THESIS ENDOMETRIAL HYPERPLASIAS IN PERIMENOPAUSE SUMMARY

CLEAR COVERAGE HYSTERECTOMY CHECKLISTS

5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe

PALM-COEIN: Your AUB Counseling Guide

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

Coexistence of Endometriosis and Uterine Dysfunction in Infertile Women

Endometriosis د. نجمه محمود كلية الطب جامعة بغداد فرع النسائية والتوليد

Pelvic Pain. What you need to know. 139 Dumaresq Street Campbelltown Phone Fax

Female Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan

Frequency of menses. Duration of menses 3 days to 7 days. Flow/amount of menses Average blood loss with menstruation is 60-80cc.

Contents: Benign Diseases of the Uterus

Adenomyosis: Back to the future?

Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine

Pelvic Pain: Overlooked

Palm Beach Obstetrics & Gynecology, PA

INFERTILITY CAUSES. Basic evaluation of the female

Endometriosis of the Appendix Resulting in Perforated Appendicitis

My Patient Has Pelvic Pain. David A. Kenny DO

Fibroid Tumors And Endometriosis By Susan M. Lark READ ONLINE

UTERINE LEIOMYOSARCOMA. About Uterine leiomyosarcoma

5/5/2010 FINANCIAL DISCLOSURE. Abnormal Uterine Bleeding. Is This A Problem? About me % of visits to gynecologist

Gynecologic Decision Making Based on Sonographic Findings

4 Mousa Al-abbadi. Ola Al-juneidi. Abdul-rahman Ibrahim

ADENOMYOSIS CHRONIC PELVIC PAIN IN WOMEN IMAGING CHRONIC PELVIC PAIN IN WOMEN CHRONIC PELVIC PAIN IN WOMEN ADENOMYOSIS: PATHOLOGY ADENOMYOSIS

Types of Hysterectomy for Non-cancerous Conditions: Understanding Your Doctor s Recommendations


A Rare Case of Invasive Squamous Cell Carcinoma of Cervix Extending to Endometrium and Right Fallopian Tube

ENDOMETRIOSIS WITH LYMPHATIC SPREAD P. Narmadha 1, P. Viswanathan 2, Rehana Tippoo 3, U. Manohar 4, Lavanya Kumari 5

Endometriosis. *Chocolate cyst in the ovary

4 Proven Ways of How To Treat Fibroids Naturally

Endometrial line thickness in different conditions.

Definition Endometriosis is the presence of functioning endometrial tissue outside the cavity of the uterus.

Female genital tract II.

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

Question Bank III - BHMS

Endometriosis and Infertility - FAQs

Endometriosis. Assoc.Prof.Pawin Puapornpong, Faculty of Medicine, Srinakharinwirot University.

Aulia Rahman, S. Ked Endang Sri Wahyuni, S. Ked Nova Faradilla, S. Ked

Hysterectomy. What is a hysterectomy? Why is hysterectomy done? Are there alternatives to hysterectomy?

Adenomyosis by myometrial Invasion of endometriosis: Comparison with typical adenomyosis

Polycystic ovarian disease and Endometriosis

Managing infertility when adenomyosis and endometriosis co-exist

Fibroid mapping. Haitham Hamoda MD FRCOG Consultant Gynaecologist, Subspecialist in Reproductive Medicine & Surgery King s College Hospital

Chapter 100 Gynecologic Disorders

Menstrual Disorders & Ambulatory Gynaecology

Page # 1. Endometrium. Cellular Components. Anatomical Regions. Management of SIL Thomas C. Wright, Jr. Most common diseases:

Freedom of Information


The many faces of Endometriosis

UTERINE LESIONS ASSOCIATED WITH FIBROMYOMA*

4:00 into mp3 file Huang_342831_5_v1.mp3

Dr Devashana Gupta. Repromed Auckland. 17:30-18:00 Fibroids, Endometriosis and DUB

CNGOF Guidelines for the Management of Endometriosis

Histopathological Study of Spectrum of Lesions Seen in Surgically Resected Specimens of Fallopian Tube

Fertility Following Myomectomy

Endometrial Hyperplasia: A Clinicopathological Study in a Tertiary Care Hospital

Endometrial adenocarcinoma icd 10 code

PELVIC PAIN IN GYNECOLOGY

Endometriosis. What you need to know. 139 Dumaresq Street Campbelltown Phone Fax

Endometriosis: An Overview

Bursting Pelvic Inflammatory Disease.

Laparoscopy-Hysteroscopy

Moneli Golara Consultant Obstetrician and Gynaecologist Barnet Hospital Royal Free NHS Trust

Dysmenorrhoea Gynaecology د.شيماءعبداالميرالجميلي. Aetiology of secondary dysmenorrhea

Pathology of the female genital tract

Grand Rounds Mullerian Anomalies. Sara Schaenzer, PGY-3 9/26/18

Evidence Based Guideline Intrauterine Ablation or Resection of the Endometrium

Chronic Pelvic Pain Case Study

PRM Associated Endometrial Change Introduction & Illustrations 12-Feb-2012

Conflicts 10/5/2016. Abnormal Uterine Bleeding. Objectives Review diagnosis and updated nomenclature. Management options for acute and chronic AUB.

Laparoscopy and Hysteroscopy

Difference Between PCOS and Endometriosis

Endometrial Cancer. Incidence. Types 3/25/2019

Endometriosis an Enigma- Review Article

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Key words: Adenocarcinoma, Adenomyosis, Biopsy, Ovary, Small Cell Lung Carcinoma.

DIP.G.O. EXAMINATION 2007

Correlation of Endometrial Thickness with the Histopathological Pattern of Endometrium in Postmenopausal Bleeding

X-Plain Ovarian Cancer Reference Summary

Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital

Clinicopathological Study of Uterine Leiomyomas: A Multicentric Study in Rural Population

bleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the

Understanding and Managing Lynch Syndrome

A case of extremely rare ovarian tumor: Primary ovarian adenomyoma

One of the commonest gynecological cancers,especially in white Americans.

Bursting Pelvic Inflammatory Disease.

Endometrial adenocarcinoma icd 10 code

Audit changes clinical practice! impact on rate of justification of hysterectomy indication

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

CURRICULUM VITAE. (Revised 2018) Wendy S. Humphrey, M.D. F.A.C.O.G Adjunct Clinical Professor of Obstetrics and Gynecology

Chronic Pelvic Pain. Bridget Kamen, MD Obstetrics and Gynecology, Confluence Health. I have no disclosures

Information leaflet on. Laparoscopic Treatment of Endometriosis

Atypical Hyperplasia/EIN

Female Reproductive System

Investigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle?

Received, June 29, 1904; accepted for publication

reproductive organs. Malignant neoplasms. 4. Inflammatory disorders of female reproductive organs 2 5. Infertility. Family planning.

Levosert levonorgestrel 20mcg/24hour intrauterine device

Transcription:

UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE Ph.D. THESIS ADENOMYOSIS. ETIOPHATOGENICAL, DIAGNOSTIC AND THERAPEUTICAL CONSIDERATIONS ABSTRACT SCIENTIFIC COORDINATOR: PROF. DR. MIHAI B. BRĂILA, Ph.D. Ph.D. Candidate: DR. POPESCU CRISTIAN-IOAN CRAIOVA 2011

Key words: mullerian blastem, endometriosis, adenomyosis, menorrhagia, hysterectomy. INTRODUCTION Adenomyosis is a frequent condition which is commonly expressed by menorrhagia in premenopausal women. Other conditions such as: benign endometrial hyperplasia, endometrial adenocarcinoma, intracavitary myomas, dysfunctional uterine bleedings present themselves with menorrhagia as the main symptom and, most frequently, at the same age as adenomyosis. Usually, the diagnosis of adenomyosis is a histopathological one. Nevertheless, efforts should be made by all practitioners in order to establish the diagnosis as soon as possible because adenomyosis is a surgical condition. GENERAL SECTION Chapter 1. Reproductive embryogenesis The development of the ovary, genital ducts and vagina, as well as molecular regulation of this development are thoroughly presented. Chapter 2. Endometriosis. Etiopathology. Diagnostic. Therapeutic Strategy Endometriosis is a condition characterized by the ectopic presence of endometrial tissue (glands and stroma). John Sampson was the first author who suggested, in 1921, that pelvic endometriosis arises from seedings of ovarian endometriosis. He hypothesized that the retrograde flow of endometrial tissue is the probable

cause of the disease. The present theories concerning the etiopathogeny of endometriosis are the following: 1. The theory of endometrial tissue transplantation 2. The theory of coelomic metaplasia 3. The theory of induction The clinical findings, the imaging, the role of CA-125, laparoscopy, classification and staging, as well as the therapeutic strategy are fully discussed. Chapter 3. Dysfunctional uterine bleedings The physiopathology and the diagnosis of dysfunctional uterine bleedings, especially in premenopausal women are presented. SPECIAL SECTION Chapter 4. Adenomyosis. Genetic or acquired pathology? The importance of adenomyosis in current practice Adenomyosis was described for the first time by Rokitansky in 1860 and more clearly defined by von Recklinghausen in 1896 under the term of adenomyomata and cystadenomata of the uterus and the fallopian tube wall. The name of adenomyosis was used first by Frankl in 1925. Adenomyosis is characterized by the presence of multiple intramyometrial small ducts lined by endometrial mucosa (glands and stroma) and communicating with the uterine cavity. Cullen, in 1908, stated that adenomyosis represents the migration step by step of normal endometrium into the myometrium.

Traditionally, the histologic diagnosis of adenomyosis is established when endometrial glands and stroma are seen at least at one small power microscopic field under the endometrial junction. Hoang Ngoc Minh et al, in 1992, gave another explanation to the intramyometrial ducts: glandular tubes which are originating in the mullerian blastem and migrate from the myometrium towards the uterine cavity. The proliferative potential of the mullerian blastem cells could be activated in the adult life by the presence of some inductors, such as fragments of endometrial tissue carried during menses into the vascular return system of the uterus, catamenial products of degradation transported into the transition zone: proteins, enzymes, freed from the lysosomes of the endometrial disintegrated cells; different other substances which can modify the subcellular receptors, the intercellular matrix or the activity of some growth factors. Adenomyosis should usually be considered in a woman of 40 to 50 years presenting dysmenorrhea and menorrhagia of progressive intensity, with a generally enlarged, firm and sensible uterus. The preoperative diagnosis is sometimes difficult because the dysfunctional uterine bleedings and the small, multiple leiomyoma could present themselves in a similar way. The HSG, the ultrasound examination and the MRI are useful tools in establishing the diagnosis. The uterine curettage does not help in establishing the diagnosis and is not an efficient method of treatment, even though is a frequently practiced due to the presence of heavy metrorrhagia. The small amount of the estrogen receptors and the total absence in up to 40% of the progesterone receptors explain why all the attempts of progestative or estro-progestative treatments are doomed to failure. The GnRH agonistics therapy shrinks the uterus and abolishes the menorrhagia and dysmenorrhea, but the symptomatology reappears after the treatment. That is why the surgical treatment remains the only logical issue for adenomyosis.

Chapter 5. Material and Methods My study is a retrospective study and covers a period of ten years (2001 2010). The study group included all the patients admitted between 2001 2010 in which the diagnosis of adenomyosis was histopathologicaly confirmed. We therefore analyzed all the cases in which a hysterectomy was performed and a final histopathologic examination was obtained. From a total of 2570 hysterectomies performed during this period, the diagnosis of adenomyosis was histopathologicaly confirmed in 779 cases, that is in 31% of the hysterectomies. Chapter 6. Results and Discussions The general incidence of adenomyosis is 31% of all hysterectomies, whatever the preoperative indication. The C-section or the myometrectomy do not appear to be risk factors for adenomyosis in our study, as was formally stated by Harris et al. 75.35% of cases with adenomyosis belonged to the 41 to 50 years age group. 82% were parous women and 89% had at least one abortion in their medical history. In 83.54% of cases the main symptom was menorrhagia, while dysmenorrhea was the main complaint in 37.97%. The association between fibromyoma and endometrial hyperplasia with adenomyosis was present in 65%, while the association between fibromyoma or endometrial hyperplasia alone with adenomyosis was 20% and 10% respectively. 15% of all the patients in our study followed different regimens of preoperative hormonal treatments. We were able to establish the preoperative diagnosis of adenomyosis in only 21 cases using HSG, 3D/4D ultrasonography or MRI.

Chapter 7. Conclusions 1. Adenomyosis is a disembryoplasic condition characterized by the presence of intramyometrial ducts lined by endometrial cells and stroma whose main feature is the weak expression of estrogen receptors and the almost total absence of progesterone receptors. The practical issue of this facts is that the adenomyosis lesions do not respond to estro-progestative regimens and respond, only during the treatment, to GnRH agonists. In our study group, 15% of the patients with the final diagnosis of adenomyosis have followed preoperative progestative treatment with in fact meant a loss of time and money. 2. As shown in the literature, neither the C-section nor the myometrectomy are risk factors for adenomyosis. This in an indirect argument in favor of the disembryoplasic hypothesis. 3. The same explanation is found for the fact that in our study group the maximum incidence of adenomyosis was among adult women, over 85% of our cases were identified in women past 41 years old. 4. We have noticed an association of adenomyosis with endometrial hyperplasia in 75% and with fibromyoma in 85% of the cases. Both the fibromyoma and the endometrial hyperplasia have the same etiopathogenesis: the hyperestrogenic micro and macro climate, which is not the case for the adenomyosis. 5. In a pacient in her forties with a uterus slightly enlarged and menorrhagia, in which a biopsy reveals an endometrial hyperplasia, it is difficult to establish if the menorrhagia is the

consequence of the hyperplasia associated with fibromyoma or/and of a simultaneous adenomyosis. 6. Like other practitioners, I have noticed that the only efficient therapeutic path in adenomyosis is the surgical treatment, mostly total hysterectomy with or without adnexectomy. It seems obvious to avoid useless conservatory treatment and this can only be done by establishing the preoperative diagnosis of adenomyosis as soon as possible. 7. Unfortunately there are no available reliable biochemical, immunological or genetic markers to point out the predisposition of some women for developing adenomyosis. The discovery, in the future, of such markers its likely to facilitate an early highlighting of the intramyometrial lesions and the establishing of a quick diagnosis. 8. Adenomyosis remains an underdiagnosed condition, on one side due to the common symptomatology shared with fibromyoma associated with endometrial hyperplasia and the on the other hand due to the fact that although adenomyosis is frequently suspected, the preoperative diagnosis is difficult to sustain because of the lack of usual accessibility to advanced investigations (MRI). 9. As any gynecologist should think that endometriosis is present in one out of ten examined patients, he should also think that almost one third of the performed hysterectomies could have as a unique or associated indication the adenomyosis.

Curriculum Vitae Personal information First name(s) / Surname(s) Cristian-Ioan, Popescu Address(es) No 9, Street Iacob Negruzzi, Bucharest, Romania Telephone(s) +4021 2234630 Mobile: +40744542276 E-mail cristianpopescu53@gmail.com Nationality Romanian Date of birth 7 th of August 1953 Gender Male Occupational field Work experience Obstetrics-Gynecology 8000 attended or supervised births 2000 C-sections Advanced surgical proficiency in abdominal and vaginal approach Practice Resident Instructor in Clinical Hospital Caritas since 2001 Member of the Coordination Group for the Romanian Clinical Guides in Obstetrics and Gynecology RoNeonat Project Occupation or position held Chief Of Department of Obstetrics and Gynecology III 01/02/2009 01/09/2009 Clinical Hospital Caritas Acad. N. Cajal 01/05/2010 31/03/2011 Obstetricien-Gynecologue Acoucheur Clinique du Bien-Naitre, Paris 01/09/2009 31/03/2010 Senior Practitioner in Obstetrics and Gynecology Clinical Hospital Caritas Acad. N. Cajal 2001 2009 Chief Of Department of Obstetrics and Gynecology Municipal Hospital Oltenita 1988 2001 Specialist in Obstetrics and Gynecology County Hospital Calarasi 1985 1988 Rezident in Obstetrics and Gynecology Emergency University Hospital of Bucharest 1982 1985 Intern Emergency University Hospital of Bucharest 1978 1982

Education and training Dates 2004 Doctoral Studies 1990 Senior Practitioner in Obstetrics and Gynecology 1985 Specialist in Obstetrics and Gynecology 1982 Rezidency Addmision Exam 1978 Graduated from Faculty of Medicine-University of Medicine and Pharmacy Carol Davila Bucharest 1972-1978 Student of the Faculty of Medicine-University of Medicine and Pharmacy Carol Davila Bucharest 1968-1972 Mihai Viteazul Lyceum Bucharest Personal skills and competences Native language Romanian Other language(s) Self-assessment Understanding Speaking Writing European level (*) Listening Reading Spoken interaction Spoken production English C2 C2 C2 C2 C2 French C2 C2 C2 C2 C2 (*) Common European Framework of Reference for Languages Social skills and competences Team spirit Ability to adapt to multicultural environments Good communication skills Technical skills and competences Acquired surgical abilities Driving licence Full, clean, driving license since 1973 Additional information Hobbies: Literature Sports Traveling Date: Signature: 13.06.2011 Cristian Ioan Popescu